Related Experiment Videos
Carvedilol overdose
P Hantson1, J Y Lambermont, G Simoens
1Department of Intensive Care, Cliniques Universitaires St-Luc, Brussels, Belgium. hantson@rean.ucl.ac.be
Acta Cardiologica
|January 1, 1997
Insights
Carvedilol, a non-selective beta-blocker with alpha-1 blockade, effectively treats hypertension and angina. It is also being investigated for congestive heart failure treatment.
Area of Science:
- Pharmacology
- Cardiovascular Medicine
Background:
- Carvedilol is a non-selective beta-adrenoceptor antagonist.
- It exhibits peripheral vasodilation through alpha-1 adrenergic blockade.
Observation:
- Carvedilol has demonstrated efficacy in managing mild-to-moderate hypertension.
- The drug is also effective for angina treatment.
Findings:
- Carvedilol's dual mechanism of action contributes to its therapeutic effects.
- Clinical investigations are exploring its utility in congestive heart failure.
Implications:
- Carvedilol represents a significant therapeutic option for cardiovascular conditions.
- Further research may expand its clinical applications in heart failure management.
Abstract:
Carvedilol is a non selective beta-adrenoceptor antagonist which also causes peripheral vasodilation primarily via alpha 1-adrenergic blockade (Strein et al., 1987, McTavish et al., 1993). It has been shown effective in the treatment of mild-to-moderate hypertension and angina, and is currently under investigation in patients with congestive heart failure.